Alpha haemoglobin‐stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment-Reference-Cited by-同舟云学术

Alpha haemoglobin‐stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment

Published:2021-08-10 Issue:1 Volume:196 Page:183-192
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Vasseur Corinne¹²^ORCID,Domingues‐Hamdi Elisa¹²,Pakdaman Sadaf¹²³,Galactéros Frédéric¹²⁴,Baudin‐Creuza Véronique¹²^ORCID

Affiliation:

1. Inserm U955‐IMRB Team Pirenne Univ Paris Est Créteil CréteilFrance

2. Laboratory of Excellence GR‐Ex ParisFrance

3. Etablissement Français du Sang (EFS) Ile de France‐Mondor CréteilFrance

4. Unité des Maladies Génétiques du Globule Rouge Hôpital Universitaire Henri Mondor (AP‐HP) Créteil France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17728

Reference24 articles.

1. An abundant erythroid protein that stabilizes free α-haemoglobin

2. Biophysical Characterization of the α-Globin Binding Protein α-Hemoglobin Stabilizing Protein

3. Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia

4. alpha-Haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia

5. α-Haemoglobin stabilising protein expression is influenced by mean cell haemoglobin and HbF levels in HbE/β-thalassaemia individuals

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management;International Journal of Molecular Sciences;2024-03-17